Dutch Software Company GENALICE on Friday declared that it has reached an agreement on a multi-million euro capital investment from Redbrae, a consortium of US- and UK-based private equity investors.
The investment consortium has a strong network in the United States, followed by the United Kingdom and Middle East. It has been working with GENALICE for the past year. The successful validation and launch of GENALICE MAP, the company’s groundbreaking DNA data processing solution, formed the basis for the latest financial injection that will afford significant backing to accelerate further product development and distribution.
Lead investor Zaheer Sardar, notes: “With the successful validation of GENALICE MAP, we really have found a major game changer in the field of genomics. Big data analysis is a critical problem in this area, and we are delighted to back a company that has developed an innovative product resulting in greater accuracy, improved speed and lower costs. Our investment will contribute to accelerating this exciting phase of the GENALICE story.”
During a 24-hour webcast in December 2013, GENALICE showcased MAP’s robustness and spectacular performance.